EJNMMI Radiopharmacy and Chemistry (May 2024)
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
- Jun Toyohara,
- Danielle Vugts,
- Oliver C. Kiss,
- Sergio Todde,
- Xiang-Guo Li,
- Zhibo Liu,
- Zhi Yang,
- Nic Gillings,
- Emiliano Cazzola,
- Wiktor Szymanski,
- Nick van der Meulen,
- Raymond Reilly,
- Carlotta Taddei,
- Ralf Schirrmacher,
- Zijing Li,
- Yohannes Jorge Lagebo,
- Naoual Bentaleb,
- Marta de Souza Albernaz,
- Suzanne Lapi,
- Caterina Ramogida,
- Archana Mukherjee,
- Javier Ajenjo,
- Winnie Deuther-Conrad,
- Cécile Bourdeau
Affiliations
- Jun Toyohara
- Tokyo Metropolitan Institute for Geriatrics and Gerontology
- Danielle Vugts
- Amsterdam University Medical Center
- Oliver C. Kiss
- Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR)
- Sergio Todde
- University of Milano-Bicoccia, Tecnomed Foundation
- Xiang-Guo Li
- Turku PET Centre and Department of Chemistry, and InFLAMES Research Flagship Center, University of Turku
- Zhibo Liu
- Peking University
- Zhi Yang
- Peking University Cancer Hospital & Institute
- Nic Gillings
- Copenhagen University Rigshospitalet
- Emiliano Cazzola
- Sacro Cuore Hospital
- Wiktor Szymanski
- University of Groningen
- Nick van der Meulen
- Paul Scherrer Institute (PSI)
- Raymond Reilly
- University of Toronto
- Carlotta Taddei
- Life Molecular Imaging GmbH
- Ralf Schirrmacher
- University of Alberta
- Zijing Li
- Xiamen University
- Yohannes Jorge Lagebo
- Addis Ababa University
- Naoual Bentaleb
- National Center for Nuclear Energy, Science and Technology-CNESTEN
- Marta de Souza Albernaz
- University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro
- Suzanne Lapi
- University of Alabama at Birmingham
- Caterina Ramogida
- Simon Fraser University
- Archana Mukherjee
- Bhabha Atomic Research Center and Homi Bhabha National Institute
- Javier Ajenjo
- Molecular Imaging Program at Stanford (MIPS), Dept of Radiology, School of Medicine, Stanford University
- Winnie Deuther-Conrad
- Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR)
- Cécile Bourdeau
- GIP Arronax
- DOI
- https://doi.org/10.1186/s41181-024-00268-w
- Journal volume & issue
-
Vol. 9,
no. 1
pp. 1 – 20
Abstract
Abstract Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main body This selection of highlights provides commentary on 24 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals. Conclusion Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.
Keywords
- Highlight articles
- Radiochemistry
- Radiopharmacy
- Radiopharmaceutical sciences
- Nuclear medicine
- Trends in radiopharmaceutical sciences
